All Stories

  1. The Role of MicroRNA in Pathogenesis and as Markers of HCV Chronic Infection
  2. The Roles of Carcinoembryonic Antigen in Liver Metastasis and Therapeutic Approaches
  3. Recombinant adenovirus infection suppresses hTERT expression through virus-associated RNA-mediated induction of type 1 interferon
  4. Selective expression of transgene using hypoxia-inducible trans-splicing group I intron ribozyme
  5. Conditional and Target-Specific Transgene Induction through RNA Replacement Using an Allosteric Trans-Splicing Ribozyme
  6. In vitro selection of RNA aptamers that selectively bind danofloxacin
  7. The role of microRNAs in Hepatitis C Virus replication and related liver diseases
  8. Use of Tumor-Targeting Trans-Splicing Ribozyme for Cancer Treatment
  9. In vitro selection of RNA aptamer specific to Staphylococcus aureus
  10. Induced Degradation of Tat by Nucleocapsid (NC) via the Proteasome Pathway and Its Effect on HIV Transcription
  11. Inhibition of Hepatitis C Virus (HCV) Replication by Specific RNA Aptamers against HCV NS5B RNA Replicase
  12. Carbon Nanotube-Patterned Surface-Based Recognition of Carcinoembryonic Antigens in Tumor Cells for Cancer Diagnosis
  13. An RNA Aptamer That Binds Carcinoembryonic Antigen Inhibits Hepatic Metastasis of Colon Cancer Cells in Mice
  14. Rapid Detection of Food Pathogens Using RNA Aptamers-Immobilized Slide
  15. Cancer-Specific Induction of Adenoviral E1A Expression by Group I Intron-Based Trans-Splicing Ribozyme
  16. Selective regression of cancer cells expressing a splicing variant of AIMP2 through targeted RNA replacement by trans-splicing ribozyme
  17. Hepatitis C Virus Replication-Specific Inhibition of MicroRNA Activity with Self-Cleavable Allosteric Ribozyme
  18. Regression of hepatocarcinoma cells using RNA aptamer specific to alpha-fetoprotein
  19. Introducing the Korean Oligonucleotide Therapeutics Society
  20. Intracellular efficacy of tumor-targeting group I intron-based trans-splicing ribozyme
  21. Identification of RNA Aptamer Specific to Mutant KRAS Protein
  22. Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs
  23. In Vivo Reprogramming of Human Telomerase Reverse Transcriptase (hTERT) by Trans-Splicing Ribozyme to Target Tumor Cells
  24. Selection of RNA aptamers specific to active prostate-specific antigen
  25. Sequence and Structural Features of RNA Aptamer Against Myasthenic Autoantibodies
  26. RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein
  27. hnRNP L is required for the translation mediated by HCV IRES
  28. In Vivo Reprogramming of hTERT by Trans-splicing Ribozyme to Target Tumor Cells
  29. Gene expression responses in vivo by human telomerase reverse transcriptase (hTERT)-targeting trans-splicing ribozyme
  30. Molecular imaging of endogenous mRNA expression in a mouse tumor model by adenovirus harboringtrans-splicing ribozyme
  31. Targeted retardation of hepatocarcinoma cells by specific replacement of alpha-fetoprotein RNA
  32. Selective Regression of Cells Expressing Mouse Cytoskeleton-Associated Protein 2 Transcript by Trans -Splicing Ribozyme
  33. Ribozyme-mediated selective killing of cancer cells expressing carcinoembryonic antigen RNA by targeted trans-splicing
  34. Cancer-selective induction of cytotoxicity by tissue-specific expression of targetedtrans-splicing ribozyme
  35. Specific Regression of Human Cancer Cells by Ribozyme-Mediated Targeted Replacement of Tumor-Specific Transcript
  36. Tumor-specific gene delivery using RNA-targeting Tetrahymena group I intron
  37. Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus
  38. Computational analysis of hydrogen bonds in protein-RNA complexes for interaction patterns
  39. Prevention of passively transferred experimental autoimmune myasthenia gravis by an in vitro selected RNA aptamer
  40. Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing
  41. In vitro selection of specific RNA inhibitors of NFATc
  42. Improvement of RNA Aptamer Activity against Myasthenic Autoantibodies by Extended Sequence Selection
  43. Trans-Splicing Ribozymes as Potential HIV Gene Inhibitors
  44. Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies
  45. Tagging ribozyme reaction sites to follow trans–splicing in mammalian cells
  46. Inhibition of HIV-1 with intracellular immunization with RNA decoys
  47. Trans-Splicing Reactions by Ribozymes